Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Diagnostic and Interventional Radiology in Neuroendocrine Tumor"
A special issue of Tomography (ISSN 2379-139X). This special issue belongs to the section "Neuroimaging".
Deadline for manuscript submissions: 30 June 2023 | Viewed by 1416
Special Issue Editor
Interests: PET; nuclear medicine; neuroendocrine tumors; molecular imaging; PET/CT; PET/MRI
Special Issue Information
Neuroendocrine tumors (NETs) are a group of rare and heterogeneous neoplasms with a variegated site of origin (even though they are located in the gastro-entero-pancreatic (GEP) sites in about 60% of cases and in the lung in approximately 30% of cases), but their incidence has risen in the last few decades partly due to advances in early detection and localization with the current imaging modalities, both morphological and functional. NETs are characterized by the peculiar and frequent expression on cell surfaces of somatostatin receptors, which represents the ideal target for molecular imaging and therapy (i.e., somatostatin analogues (SSAs) radiotracers and peptide-receptor radionuclide therapy (PRRT)).
Despite the development of radiologic imaging, the detection and follow-up of NETs still pose a diagnostic challenge due to the heterogeneity of NETs, their relatively long-term growth, and small size of the primary tumor. Regardless of imaging modality, dynamic contrast-enhanced imaging is essential for evaluation of NETs. In general, CT scan is typically the primary imaging modality for evaluating NETs. MRI is used as a complementary modality, being superior to other modalities to assess liver metastasis.
Nuclear medicine imaging is also widely used in NET assessment, especially after the advent of radioligand therapy, e.g., PRRT, to evaluate its feasibility and the subsequent response to therapy.
This Special Issue will focus on research papers, perspectives, and reviews informing readers about the role of current imaging modalities, both morphological and functional, in the evaluation of neuroendocrine tumors from characterization to assessment of treatment response and detection of early recurrence.
Dr. Priscilla Guglielmo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tomography is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neuroendocrine tumors
- molecular imaging
- interventional radiology
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.